TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026?

TransMedics remains the top dog in its industry and may have a widening moat. The founder-led company's shares have risen eightfold since 2019.
Open original source
TransMedics remains the top dog in its industry and may have a widening moat. The founder-led company's shares have risen eightfold since 2019.
Open original source